Tag: pharmaceutical competition
16 Nov
Antitrust Issues in Generic Substitution: How Drug Companies Block Cheaper Alternatives
Drug companies are using legal loopholes to block cheaper generic drugs by withdrawing original formulations and launching minor reformulations. This tactic, called product hopping, costs patients and taxpayers billions each year.
Read MoreRecent Posts
-
Bridging Studies for NTI Generics: Ensuring Safety and Efficacy
-
Vitamin K Foods on Warfarin: How to Eat Consistently for Stable Blood Thinners
-
Antitrust Issues in Generic Substitution: How Drug Companies Block Cheaper Alternatives
-
How to Understand Biosimilars and Their Cost Implications
-
Licensed Pharmacies: How to Verify Your Pharmacy Is Legitimate and Avoid Counterfeit Drugs
